New Key Statistics Module, Z-Score and F-Score
NAS:KPRX Key Ratios
| Market Cap $ M | 10.05 |
| Enterprise Value $ M | -19.09 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 2.38 |
| Price/Book | 0.34 |
| Price/Sales | 0.80 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 2.21 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 16.00 |
| EPS (TTM) $ | -4.81 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 34.50 |
| 5-y EBITDA Growth Rate % | 51.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.97 |
| EV-to-EBITDA | -7.90 |
| PEG | -- |
| Shares Outstanding M | 3.00 |
| Net Margin (%) | 34.68 |
| Operating Margin % | 38.09 |
| Pre-tax Margin (%) | 35.25 |
| Quick Ratio | 8.97 |
| Current Ratio | 8.97 |
| ROA % (ttm) | 18.33 |
| ROE % (ttm) | 24.72 |
| ROIC % (ttm) | 64.86 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.57 |
KPRX Number of Guru Trades
KPRX Volume of Guru Trades
Gurus Latest Trades with NAS:KPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KPRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kiora Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:KPRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers